As we navigate this new reality of social distancing, it behooves us to discover new ways to stay informed and connect with our industry peers.

PRINCETON, N.J. (PRWEB)
April 14, 2020

Systech, the leader in digital brand protection, today announced it is providing a complimentary online weekly series of conversational webinars. These sessions span global supply chain issues including brand protection, with a focus on how to stay one step ahead of increasingly sophisticated counterfeiters and gray market criminals. The Brand Protection Innovation Series begins Wednesday, April 15, 2020.

“As we navigate this new reality of social distancing both personally and professionally, it behooves us to discover new ways to stay informed and connect with our industry peers. This is what inspired Systech to join forces with customers and partners – experts across industries – to launch the series,” says Jefferson Barr, vice president of marketing at Systech.

Anyone from the pharmaceutical, cosmetics and beauty, wine and spirits, food and beverage, and other industries is invited to subscribe to the 20-minute live conversations. Industry experts and academia will converse on how to tackle and solve difficult global supply chain challenges. Topics include:

• 
  Product counterfeiting and diversion
• Supply chain track and trace
• Intelligent packaging solutions
• Consumer mobile engagement
• Innovative technologies that increase supply chain visibility
• Understanding how to measure brand protection ROI

Listeners are encouraged to bring insights and ideas to the conversation. This is a weekly series running every Wednesday at 11am ET. The first two episodes are April 15 and April 20.

April 15 – Susanne Somerville, CEO of Chronicled

Saleable returns and Blockchain for the pharma supply chain.

April 22 – David Yingling, Brand Protection and Product Security, Johnson & Johnson

Get a look inside how Johnson & Johnson disrupts the illicit trader’s ability to mimic products and how they’re making it easier to identify what is genuine vs. suspect.

Register here to tune in to the complimentary Brand Protection Innovation Series. All conversations will be recorded and available later as on-demand episodes.

About Systech:

Systech International, a Princeton, New Jersey-based company, has developed an innovative software suite of authentication and traceability solutions to combat counterfeiting, prevent diversion and meet regulatory compliance. Built on decades of experience as the leader in pharmaceutical serialization, Systech is revolutionizing brand protection with its comprehensive suite that delivers the real-time insight, actionable product data, digital connectivity and consumer engagement functionality needed to fight supply chain threats. Global brands across industries rely on Systech to keep their products authentic, safe and connected as they move through the supply chain.

Media Contact:

Jefferson Barr, VP Marketing

+1 609-235-8446

Jefferson.barr@systechone.com

Share article on social media or email:

Cardiologists need real-time, full disclosure data from remote cardiac monitoring and accurate alerts for ambulatory homebound cardiovascular patients and COVID-19 sufferers for quick action that saves lives,” Dr. Movsowitz says

WALTHAM, Mass. (PRWEB)
April 14, 2020

With nearly half of all adults in the U.S. diagnosed with some form of cardiovascular disease, COVID-19 introduces a new wave of challenges for the healthcare industry.(1) As data emerges to show the novel coronavirus’s contribution to heart damage, cardiologists are currently faced with a major treatment crisis. Leading ambulatory cardiac monitoring provider InfoBionic is focused on meeting the critical demand brought on by the pandemic to find innovative solutions when it comes to heart healthcare. “Cardiologists desperately need remote cardiac monitoring for condition tracking of heart and COVID-19 patients that is fast, accurate, effective, simple to use, non-invasive and provides condition monitoring versatility to save more lives without physically seeing patients,” says Stuart Long, CEO of InfoBionic.

In addition to lung damage, many COVID-19 patients are also developing heart problems and dying of cardiac arrest. According to research from China, 19% of the novel coronavirus patients exhibited signs of heart damage, with 51% of those cases significantly more likely to be fatal.(2) About 10% of patients with pre-existing cardiovascular disease (CVD) who contract COVID-19 will die, compared to the mere 1% of patients who are otherwise considered to be healthy.(3)

Furthermore, this pandemic is happening during a period where countless cardiologists are discovering that cardiac and stroke patients have largely disappeared from hospitals and practices. Many cardiologists are stating that patient appointments have decreased by as much as 60% due to COVID-19.(4) This reality is being driven both by hospitals prioritizing COVID-19 patients as well as patients with preexisting heart conditions avoiding hospitals or cardiology offices due to their concern about the transmission of the virus. This fear is delaying treatment, which results in an increase in the severity of conditions and a higher risk of death among these patients.

Forty-two percent of Medicare beneficiaries aged 65 years and over have at least one heart-related health condition, which is the leading cause of death and the most expensive among this group.(5) While a broad set of telehealth resources are being executed in response to COVID-19, cardiac patients have growing concerns revolving around the costs of these options, which have traditionally been excluded from Medicare coverage.

Though this has recently changed, with Centers for Medicare and Medicaid (CMS) expanding Medicare coverage for telehealth. Additionally, HHS Office for Civil Rights is working to implement more discretion when it comes to enforcing HIPAA-compliance for these tools.(6) These are crucial steps to supporting Americans with preexisting heart conditions and those that are developing such conditions due to COVID-19.

In the bigger picture, remote cardiac monitoring solutions can play a major role in the pandemic to monitor the health for a range of patients affected by heart conditions and/or COVID-19, including:

• 
  Patients with added or current medical therapy that require QT-Interval assessment and monitoring (Antiarrhythmics, antipsychotics, antibiotics, etc.)
• Patients with AFib, palpitations, syncope, near-syncope, etc.
• Those individuals restricted to their homes who require stop gap for 12-lead ECG, HR data, and 24-hr provider trend assessments
• Patients in retirement- and assisted-living communities
• Monitoring the vitals of non-COVID patients following hospital stays
• Customized tachycardia alerts as an added surrogate marker for escalation to acute care/hospitalization needs for home-isolated patients with suspected/confirmed COVID-19 diagnoses

While this is a major step forward in the fight against COVID-19, cardiologists rely on partnership from manufacturers in order to help these specialists easily, effectively, and remotely treat both cardiac patients and those with coronavirus symptoms. This was the impetus behind two innovative device delivery programs from InfoBionic:

• MailMe—a program that enables the practice to mail the MoMe® Kardia device directly to their patient at home
• ReMoteMe—a program where InfoBionic will manage the practice’s MoMe® Kardia inventory via an FDA-approved processing site

These innovative solutions are vitally important in supporting cardiologists and patients during COVID-19, according to leading electrophysiologist Dr. Colin Movsowitz of Cardiology Consultants of Philadelphia—the largest private cardiology practice in the country.

“Cardiologists need real-time, full disclosure data from remote cardiac monitoring and accurate alerts for ambulatory homebound cardiovascular patients and COVID-19 sufferers for quick action that saves lives,” Dr. Movsowitz says. “It’s imperative for companies like InfoBionic to lead the way in devoting infinite logistics, professional, and technical Medicare reimbursement support along with non-invasive remote cardiac monitoring solutions like the MoMe® Kardia platform to support that mission in every way possible within the broader healthcare system.”

About InfoBionic

InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most—physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs leverages successful careers in healthcare, IT, medical devices, and mobile technology, along with specific expertise in remote monitoring and cardiology. Their first-hand experience with the complexities of traditional cardiac arrhythmia detection and monitoring processes led to design of the transformative MoMe® Kardia platform to remove the roadblocks, thus amounting to a faster and more effective process for decision-making and diagnosis. InfoBionic is the recipient of the Frost & Sullivan 2019 North American Remote Cardiac Monitoring Technology Leadership Award. For more information, visit http://www.infobionic.com.

1. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association AHA Journal Circulation, January 21, 2019, ahajournals.org/doi/full/10.1161/CIR.0000000000000659

2. Shaobo Shi, MD1, Mu Qin, MD, Bo Shen, MD1,2,3; et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China, JAMA Cardiology journals, March 25, 2020. jamanetwork.com/journals/jamacardiology/fullarticle/2763524?resultClick=1

3. About 10% of patients with pre-existing cardiovascular disease (CVD) who contract COVID-19 will die, compared with only 1% of patients who are otherwise healthy. Dara K. Lee Lewis, MD. How does cardiovascular disease increase the risk of severe illness and death from COVID-19?, Harvard Health Blog, APRIL 04, 2020, health.harvard.edu/blog/how-does-cardiovascular-disease-increase-the-risk-of-severe-illness-and-death-from-covid-19-2020040219401

4. Harlan M. Krumholz, M.D. Where Have All the Heart Attacks Gone? The New York Times, April 6, 2020, nytimes.com/2020/04/06/well/live/coronavirus-doctors-hospitals-emergency-care-heart-attack-stroke.html

5. “Prevalence and Health Care Expenditures among Medicare Beneficiaries Aged 65 Years and Over with Heart Conditions,” CMS, 2017, cms.gov/Research-Statistics-Data-and-Systems/Research/MCBS/Data-Briefs-Items/HeartConditions_DataBrief_2017

6. Dave Muoio. FDA expands use of vital sign monitors to enable remote care, modifications during COVID-19 emergency, Mobihealth News, March 20, 2020, mobihealthnews.com/news/fda-expands-use-vital-sign-monitors-enable-remote-care-modifications-during-covid-19-emergency

# # #

Share article on social media or email:

symplr

Together, symplr and Phynd provide our shared customers with deeper provider data management capabilities to enable that vision.

HOUSTON and DALLAS (PRWEB)
April 14, 2020

symplr®, a global leader in healthcare governance, risk and compliance (“GRC”) solutions and Phynd Technologies, a leading provider data platform, today announced a strategic partnership. The partnership facilitates the seamless flow of credentialed provider data between the symplr and Phynd provider data management platforms.

symplr’s provider data management platform meets the needs of hospitals, payers, managed care organizations, CVOs, and physician groups with the only integrated end-to-end provider management solution that seamlessly streamlines processes and provides a single data source of truth for a healthcare organization’s provider information. The symplr provider management platform automates the entire provider management lifecycle, offering robust, easy-to-implement solutions for credentialing, privileging, payer enrollment, quality and performance improvement, peer review, contract management, network management, and recruiting.

The Phynd 360 platform integrates symplr’s credentialed provider data into the Phynd 360 platform’s provider data model to create a comprehensive view of all people, places and services. Phynd integrates credentialing and EHR data feeds to actively manage and share provider data for use in marketing, clinical, and claims systems across a healthcare enterprise. The integration ensures that consumers, as well as patient access and referral teams, experience a more effective and accurate provider search, so that patients are assured of finding the right provider, who accepts their health plan, and has convenient, available appointments.

“In the new consumer-driven world of healthcare, people need access to provider information that is comprehensive, accurate, and timely,” said Rick Pleczko, President and CEO of symplr. “Together, symplr and Phynd provide our shared customers with deeper provider data management capabilities to enable that vision.”

“Phynd greatly values the strong partnership we’ve established with symplr,” said Tom White, CEO of Phynd. “Our joint customers appreciate how providers credentialed and privileged in symplr flow seamlessly into Phynd’s provider data management platform, empowering organizations to easily curate and publish provider data into marketing, EHR and claims systems, websites and mobile apps, enabling best-in-class provider search for consumers and clinicians alike.”

About symplr

Founded in 2006, symplr is a global leader in enterprise Governance, Risk Management, and Compliance (GRC) SaaS solutions. symplr focuses on a single mission: to make healthcare GRC simpler and more efficient for all constituents of the global healthcare community. Our solutions span provider data management, provider credentialing services, patient safety, workforce management and vendor management. Our customers count on us every day to help protect and streamline their businesses with reliable and innovative GRC solutions. More information is available at http://www.symplr.com.

About Phynd

Phynd 360, an innovative provider data platform, serves as health systems’ central hub for all provider data. Phynd enables optimization for provider data –people, places and services – in EHR, Marketing and Claims systems via platform tools for provider enrollment, management, outreach and search across the enterprise. The nation’s most progressive health systems, including 7 of the 20 top hospitals as ranked by US News and World Report, rely on Phynd as their provider data platform. For more information about Phynd, visit http://www.phynd.com. Phynd is an Epic App Orchard member.

Share article on social media or email:

YORBA LINDA, Calif. (PRWEB)
April 14, 2020

LabRoots, the leading scientific social networking website offering premier, interactive virtual events and webinars, continues to provide cutting-edge research and findings about the latest developments in genomics and personalized medicine. To be held, April 21-23, Genetics Virtual Week will feature more than 25 educational, scientific discussions, including 3 keynote deliveries on emerging areas explored by those at the forefront in healthcare today.

The Tri-Topic program unites thought leaders, research scholars, clinicians, top scientists, and industry and academic professionals throughout pharma and biotech fields on a global front and remains as one of the key meetings covering trends, research breakthroughs and best practice examples to transform the understanding of health and disease. Back to back separate events over 7 years including Genetics & Genomics, Precision Medicine, and Molecular Diagnostics paved the way to launch, “Genetics Virtual Week,” first of its kind in LabRoots’ virtual event offerings. Unveiling a new look spanning three days with three core focuses, sessions comprise:

• Genome Editing
• The Evolution of Genome Reference Concepts
• Single Cell and Spatial Genomics
• Structural Variation
• Rare Disease in Precision Medicine
• Precision Medicine in Clinic
• Molecular Profiling – from Bench to Bedside
• Emerging Technologies in Molecular Diagnostics
• Artificial Intelligence

Kicking off GVW, the multi-day content-rich agenda offers over eight presentations in the area of Genomics. Key leaders will explore long HiFi Reads for High-Quality Genome Assemblies, Spatially Resolved Molecular Investigations of Triple Negative Breast Cancer, Single Cell Gene Expression: New Insights Through the Lens of Full Length MRNA Isoform Resolution, Single Cell Multi-Omics: Solving the Jigsaw, SNV’s to Large Structural Variation: Capturing Nucleotide Through Inter-Chromosomal Variants Through a Powerful Three-Dimensional Data Type, Latest Genome Editing Techniques and Applications, to name some of the talks. Top experts addressing the Rapid Diagnosis of Complex Rare Disease Cases Using Exome Sequencing, Clinical Evidence to Improve the Diagnosis of Rare Diseases, Clinical Applications of Estrogen Metabolism Genetic Testing, Population Health and Genetic Testing, RNA-Seq for the Detection of Gene Fusions in Tumors, Nanotherapeutics: An Insight Into Healthcare and Future Mulit-Dimensional Clinical Applications, and Leveraging Genetic Evidence Throughout the Pharma Pipeline, help round out the Precision Medicine topic with over ten discussions on the latest approaches to better health. Advantages of Digital PCR and its applications – the power of partitioning, in addition to how Biology-gated Transistors can be used for diagnostic purposes are couple of presentations shared under emerging technologies in Molecular Diagnostics.

In addition to an unprecedented lineup each sharing his or her unique insights, you will hear compelling keynote deliveries by:

• Michael Snyder, PhD, Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine: “Individualized Health” – What is Wrong with Healthcare Today.
• David Smith, PhD, Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic: “The Massively Parallel Sequencing (MPS) Revolution.”
• Kris Wood, Assistant Professor, Department of Pharmacology and Cancer Biology, Duke University: “Systematic Identification of Therapeutic Strategies that Leverage Tumor Evolution.”

“We want to transform the way healthcare is performed and bring it into the 21st century using advanced technologies, such as omics, wearables, and big data,” said Michael Snyder, Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine. “LabRoots’ platform provides a great way to showcase our current scientific understandings and new breakthroughs in the industry, especially in a time of pandemic like we are in.”

“We continue to make significant milestones in the online conference industry, where we have dedicated over 11 years to exploring the latest discoveries and contributing to the advancement of science,” said Greg Cruikshank, Chief Executive Officer of LabRoots. “We are thrilled to bring Genetics Virtual Week to the scientific community, so attendees can learn and connect with others in the fields of Genomics, Molecular Diagnostics, and Precision Medicine while gaining insights about transforming patient care and outcomes.”

Produced on LabRoots’ robust platform, this online environment with auditorium, exhibit and poster halls, and networking lounge all under one roof allows attendees to connect seamlessly across all desktop and mobile devices. By participating in this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits. This event will also provide PACE credits for clinical laboratorians, and CEU’s for Genetic Counselors, pending approval by the NSGC.

For more information or to register for the event, click here. Participants can follow the conversation online by using #LRgenetics.

About LabRoots

LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email:

“Initial telehealth solutions were costly and cumbersome, preventing many practices from considering them. COVID-19 brought about an immediate need for next-generation telehealth,” said Michael Morgan, CEO, Updox.

DUBLIN, Ohio (PRWEB)
April 14, 2020

Updox, a comprehensive Telehealth and Collaboration Platform, continues to see an unprecedented need for virtual care solutions for physicians as the novel coronavirus spreads across the U.S. Updox experienced a significant spike in demand throughout March, onboarding more than 10,000 new customer users to its HIPAA-compliant telehealth solution in just two weeks. Today, the company facilitates more than 45,000 telehealth visits per day between patients and their doctors, with that number increasing rapidly.

More than 300 million Americans are currently under orders to shelter-in-place as public health officials and providers work to contain and mitigate the coronavirus. Updox experienced a sharp increase in the demand for telehealth from mid-March, when more states began issuing stay-at-home orders and physicians needed a safe and secure way to connect with their patients.

Unlike some first-generation telehealth solutions, Updox allows patients to connect with their own physicians instead of someone unfamiliar to them. Likewise, rather than competing with physicians, the Updox platform supports practices to maintain revenue, protect staff and deliver care safely to their patients. Studies show that patients prefer receiving treatment from their own physicians, with whom they’ve developed strong, trusted relationships. In fact, according to a recent survey by Sharecare, 60% of Americans noted they would want to “access care with their primary physician if they experienced COVID-19 symptoms.”

“Initial telehealth solutions were costly and cumbersome, preventing many practices from considering them. COVID-19 brought about an immediate need for next-generation telehealth,” said Michael Morgan, CEO, Updox. “Our solution prioritizes getting practices up and running with HIPAA-compliant virtual care in one day, enabling care to continue in ways that protect staff while also maintaining established patient/provider relationships. We’re here to support physicians, not compete with them.”

Updox’s HIPAA-compliant solutions enable physicians to connect with patients in an easy-to-use way. There are no apps to download or special equipment needed. Physicians can provide safe and effective screening and treatment of their patients from the comfort of their own homes. Plus, it’s more than just video. As part of Updox’s Patient Engagement platform, after a telehealth visit, a practice can use the same system to securely email or text follow-up messages, patient forms, surveys and more.

“Post-COVID, telehealth will have forever changed the way healthcare is delivered. It strengthens the value and trust of the patient/provider relationship. Even when the patient can’t get to the practice, it opens care up in ways that some physicians wouldn’t consider before,” says Eric Weidmann, MD, South Austin Medical Clinic. “Reimbursement opportunities will continue to grow. But this has shone a light on the need for universal, easy, secure ways to deliver virtual care. That will stay with the industry.

Updox is committed to helping physicians provide seamless care. The company extended office hours to ensure providers have the support, information and answers needed during this time. Practices that wish to start using telehealth can get registered, trained and begin providing virtual care within one day. Please visit our dedicated COVID-19 resource page to learn more: https://info.updox.com/covid-19-resources

About Updox:

Changing the way healthcare connects, Updox’s telehealth solutions are part of an all-in-one collaboration platform for out-of-hospital healthcare providers. Named for the past five years to the Inc. 5000 list of America’s fastest-growing private companies, Updox is integrated with more than 100 electronic health records (EHR) and pharmacy management systems and serves more than 470,000 users and 170 million patients. Updox offers a broad set of capabilities for patient engagement, provider communications and internal productivity that work together in a secure, easy-to-use collaboration platform. Updox was created specifically for the out-of-hospital market and gives customers access to a growing platform that focuses on solutions and services to make everyone delivering healthcare happy. Learn more at http://www.updox.com or follow the company on Twitter, LinkedIn and Facebook.

Share article on social media or email:

Dr. Sarah A. Merritt, CEO & Clinical Director – Lifestream Health Center

“We treat our patients for health, and also with dignity and respect for each and every patient. Receiving this award validates our vision and mission.” – Dr. Sarah A. Merritt, MD

BOWIE, Md. (PRWEB)
April 13, 2020

Lifestream Health Center has been selected for the 2020 Best of Bowie Award in the Local Business category by the Bowie Award Program.

Each year, the Bowie Award Program identifies companies that have achieved exceptional marketing success in their local community and business category. These are local companies that enhance the positive image of small business through service to their customers and our community. These exceptional companies help make the Bowie area a great place to live, work and play.

Dr. Sarah A. Merritt, CEO and Clinical Director of Lifestream Health Center, states, “Our team is excited to be recognized as ‘best of’ in this award category. We take a patient centered, caring, and compassionate approach to the practice of Pain Management. While many facilities maintain a formulaic approach to Pain Management; we’re proud to spend time with every patient. We treat our patients for health, and also with dignity and respect for each and every patient. Receiving this award validates our vision and mission.”

Various sources of information were gathered and analyzed to choose the winners in each category. The 2020 Bowie Award Program focuses on quality, not quantity. Winners are determined based on the information gathered both internally by the Bowie Award Program and data provided by third parties.

About Lifestream Health Centers

Lifestream Health Center has been serving the Bowie/Baltimore-Washington D.C. Metropolitan area since 2000, when the practice was established by Dr. Robert Lyles. We have assembled an amazing team of highly trained pain management specialists to help our patients to solve their acute and chronic pain problems. Our center offers comprehensive pain management for acute and chronic pain problems. We recognize the value of personalized treatment plans, as all patients are not the same. For more information, visit our website at

https://lifestreamhealth.com/

About Bowie Award Program

The Bowie Award Program is an annual awards program honoring the achievements and accomplishments of local businesses throughout the Bowie area. Recognition is given to those companies that have shown the ability to use their best practices and implemented programs to generate competitive advantages and long-term value.

The Bowie Award Program was established to recognize the best of local businesses in our community. Our organization works exclusively with local business owners, trade groups, professional associations and other business advertising and marketing groups. Our mission is to recognize the small business community’s contributions to the U.S. economy. For more information, visit our website at

http://www.townbestof-information.org

About Growth Solutions Team

The Growth Solutions Team is a leading provider of Business Consulting Services including, Strategic HR, CFO Advisory, Sales & Customer Service Training, and Small Business Advisory services. Our team assists companies with growth in sales, profitability, and improved cash flows. For more information, visit the website at

https://growthsolutionsteam.com.

Share article on social media or email:

Telemedicine On Demand Call 833-TEC-FAST (833-832-3278)

“We understand access to quality care is limited due to quarantine and social distancing measures, which is why we are offering visits with our Board-Certified ER Doctors from the comfort of a patient’s home.”

SAN ANTONIO, FORT WORTH, and ARLINGTON, Texas (PRWEB)
April 13, 2020

Now patients can call or video chat The Emergency Center’s freestanding ERs for symptoms such as abdominal pain, back pain, fever, heartburn, cough, sore throat, joint pain, rash, insect bites or stings, flu like symptoms, possible COVID-19 symptoms, and more. One of their Board-Certified ERs physicians will assess the patient’s symptoms, then prescribe necessary treatment medications or determine whether the patient may require an immediate clinical visit. In the event the physician recommends further evaluation or immediate treatment, The Emergency Center is open with no wait 24/7/365. The Emergency Center honors all private health insurance for telemedicine and ER visits, and telemedicine visits are available 7 days a week from 8:00AM until 12:00AM. The Emergency Center also offers testing for flu, strep and mono, and COVID-19.

Dr. Keith Butler, CEO of The Emergency Center announces “In this unprecedented and challenging time, The Emergency Center is ready to help our patients. We understand access to quality care is limited due to quarantine and social distancing measures, which is why we are offering visits with our Board-Certified ER Doctors from the comfort of a patient’s home.”

Telemedicine limits physical contact between patients and physicians and can be a vital tool to combat the spread of infectious diseases and COVID-19. Physicians can provide appropriate advice to patients remotely, which also helps avoid crowded hospital ER waiting rooms and unnecessary trips to the emergency room. By limiting unnecessary emergency room visits, telemedicine allows hospital ERs to have more space and resources for the influx of COVID-19 patients.

Patients never need to make an appointment for telemedicine or facility visits at The Emergency Center. The Emergency Center encourages patients to protect themselves and help contain the spread of COVID-19 by calling 833-TEC-FAST (833-832-3278) for urgent and minor care needs. However, telemedicine should not be used for chest pain, cardiac arrest, stroke, or any other potentially life-threatening emergencies. The Emergency Center physicians and staff are always ready to treat medical emergencies with no wait, 24 hours a day, 7 days a week, 365 days a year.

About The Emergency Center

TEC is a leading patient-centered healthcare physicians group expanding access to the highest quality emergency medical care through its network of freestanding emergency rooms in Texas. More than urgent care centers, The Emergency Center offers a complete suite of emergency services onsite, including X-ray, 64-slice CT scanner, ultrasound, a full-service diagnostic lab, onsite pharmacy, take home MedPacks with up to 72 hours of prescriptions, and free telemedicine follow-up visits. The Emergency Center has no wait 24 hours a day, 7 days a week, 365 days a year, and honors all private insurance plans. TEC operates facilities in Fort Worth, Arlington and San Antonio and strives to be a vital part of each community it serves. The Emergency Center encourages the population not to hesitate to seek emergency care if they feel their health is in serious jeopardy.

Share article on social media or email: